IBIdoia Burgui

Idoia Burgui

*This is an algorithmically generated author record based on publicly available information.

Idoia Burgui has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Angie Rico

    Transfusion Safety Laboratory, Blood and Tissue Bank of Catalonia (BST), 08005 Barcelona, Spain

    1 shared publication
  • Ariadna Rando-Segura

    Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain

    1 shared publication
  • Brenda Martínez-González

    Department of Clinical Microbiology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Av. Reyes Católicos 2, 28040 Madrid, Spain

    1 shared publication
  • Celia Perales

    Microbes in Health and Welfare Program , Centro de Biología Molecular Severo Ochoa (CSIC-UAM), C/ Nicolás Cabrera, 1, Campus de Cantoblanco, E-28049 Madrid

    1 shared publication
  • Clara Ramirez-Serra

    Clinical Biochemistry Research Group, Vall d’Hebron Research Institute (VHIR), Biochemical Core Facilities, Vall d’Hebron University Hospital, Autonomous University Barcelona, 08035 Barcelona, Spain

    1 shared publication
  • Esteban Domingo

    Microbes in Health and Welfare Program, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid), Madrid 28049, Spain

    1 shared publication

Latest Publications

  • Open Access

    Comparison of Extracellular Vesicle Isolation Methods for miRNA Sequencing

    by Meritxell Llorens-Revull, Brenda Martínez-González, Josep Quer, Juan Ignacio Esteban, Gonzalo Núñez-Moreno, Pablo Mínguez, Idoia Burgui, Ricardo Ramos-Ruíz, María Eugenia Soria, Angie Rico, et al.

    MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.